Literature DB >> 2982750

Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.

M Packer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982750     DOI: 10.1016/0167-5273(85)90349-3

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  8 in total

1.  'First dose' hypotension and venodilatation.

Authors:  S Capewell; A Capewell
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 2.  Congestive cardiac failure: advances in management.

Authors:  V Dev; R Tandon
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

Review 3.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 4.  Optimal dosage of ACE inhibitors in older patients.

Authors:  B Tomlinson
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

5.  The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.

Authors:  P Holt; J Najm; E Sowton
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.

Authors:  S Capewell; D Taverner; W J Hannan; A L Muir
Journal:  BMJ       Date:  1989-10-14

Review 7.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

Review 8.  The role of vasodilator therapy in the treatment of severe chronic heart failure.

Authors:  M Packer
Journal:  Drugs       Date:  1986       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.